Lucite deal tombstone commemorating two related royatly transactions. Both deals involve the diabetes drug TZIELD. (23AKL274)
Lucite deal tombstone commemorating two related royatly transactions. Both deals involve the diabetes drug TZIELD. (23AKL274)
Lucite deal tombstone, incorporating spinning logos, commemorating a strategic partnership between Sansum Clinic and Sutter Health. The two non-profit heath care systems are based in California. (23ALJ228)
Custom Award recognizing contributions to the development of a medical implant, and embedding the actual device within Lucite. (23AZH106)
Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, theĀ drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
Diamond-shaped crystal deal toy commemorating a follow-on stock offering by Swiss biotech firm Oculis. (23AKL262)
Logo-themed Lucite tombstone celebrating Series B funding for Carta Healthcare. The San Francisco-based company provides a patient management platform for hospitals that makes use of artificial intelligence (AI). (23AZH141)
Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)